|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Less: Income (loss) from discontinued operations, net of tax | |||||
| Less: Gain on sale of discontinued operations, net of tax | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile income from continuing operations to net cash: | |||||
| Depreciation, depletion, amortization, and accretion | |||||
| Litigation settlement charge | |||||
| Long-lived asset impairment charges | |||||
| Recovery of receivable | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| (Gain) loss on asset dispositions | |||||
| Gain from the sale of equity method investment to related party | |||||
| Loss on sale of equity method investment | |||||
| Income from equity method investments | |||||
| Dividends received from equity method investments | |||||
| Pension settlement | |||||
| Gain on deconsolidation of subsidiaries and consolidated joint ventures | |||||
| (Increase) decrease in working capital | |||||
| Receivables | |||||
| Income taxes receivable, net | |||||
| Inventories | |||||
| Other current assets | |||||
| Payables | |||||
| Accrued expenses | |||||
| Increase in other assets | |||||
| Decrease in pension and other postretirement benefits | |||||
| Decrease in other liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities of continuing operations | |||||
| Net cash provided by operating activities of discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Purchases of marketable securities | |||||
| Sales or maturities of marketable securities | |||||
| Capital expenditures | |||||
| Net proceeds from asset dispositions | |||||
| Net proceeds from the sale of equity method investment to related party | |||||
| Net proceeds from sale of equity method investment | |||||
| Acquisition of business, including working capital adjustment | |||||
| Receipt of collection on loan from former joint venture | |||||
| Return of capital | |||||
| Insurance proceeds | |||||
| Return (deposit) of restricted cash | |||||
| Net cash (used for) provided by investing activities of continuing operations | |||||
| Net cash provided by investing activities of discontinued operations | |||||
| Net cash (used for) provided by investing activities | |||||
| Financing Activities | |||||
| Issuance of debt | |||||
| Repayment of debt | |||||
| Payment of debt issuance fees | |||||
| Issuance of common stock | |||||
| Repurchase of common stock | |||||
| Repurchases of common stock to satisfy employee tax withholding obligations | |||||
| Conditional special dividend | |||||
| Net cash used for financing activities of continuing operations | |||||
| Effect of exchange rate changes on cash | |||||
| Net decrease in cash and cash equivalents from continuing operations | |||||
| Net increase in cash and cash equivalents from discontinued operations | |||||
| Change in cash balance included in discontinued operations | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental Cash Flow Disclosures: | |||||
| Interest paid, net of interest capitalized | |||||
| Income taxes paid, net of refunds received | |||||
| Noncash Investing and Financing Activities: | |||||
| Amount in accounts payable for capital expenditures | |||||
| Reversal of USG Boral Building Products earnout | |||||
| Contribution of wholly-owned subsidiaries and joint venture investments as consideration for investment in USG Boral Building Products | |||||
| Conversion of $75 million of 10% convertible senior notes due 2018, net of discount | |||||
| Issuance of common stock upon conversion of debt | |||||
| Accrued interest on debt conversion | |||||
| Dividends Payable | |||||
Loading...